ReviewEXCLI journal2025

Recent FDA-approved kinase inhibitors for cancer therapy in 2025: A comprehensive review and perspectives.

Mateen Abbas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.